Dermatology Times

JUNE 10, 2024

Kristine Kucera, PA-C, MPAS, DHS, discusses prescribing a PDE-4 inhibitor for Mickey Bryson's psoriasis and atopic dermatitis, emphasizing the absence of FDA-approved medications like JAK inhibitors, while Bryson underscores the challenges of daily injections, likening it to insulin use.

Dermatitis 36

Dermatitis Management Injections Medical 36

US Dermatologt Partners

AUGUST 23, 2023

Atopic Dermatitis, more commonly known as eczema, is a common skin condition impacting one in 10 Americans. Dermatology Partners affiliate office Medical Dermatology Specialists in Phoenix, Arizona , “Like other chronic skin conditions, eczema is best managed with the help of a dermatologist. Millions of people in the U.S.

Eczema 36

Eczema Dermatitis Management Skin Health 36

The Dermatology Digest

AUGUST 21, 2024

Childhood obesity can contribute to the development of common immune-mediated skin diseases (IMSDs), such as alopecia areata, atopic dermatitis, and psoriasis, new research finds. Maintaining a healthy weight could potentially help lower the chances of developing these skin conditions, the researchers suggest.

Dermatitis 68

Dermatitis Diet Dermatology Medical 68

First Derm

APRIL 19, 2023

Online Dermatologist Cercarial Dermatitis (Swimmer’s itch) Medically reviewed by The Dermatologists and written by Dr. Alexander Börve Swimmer’s itch pictures initial stage U07.1 That is why it is given the name “cercarial” dermatitis. swimmers_itch_pictures_rash_papules_swelling_B65.3

Dermatitis 40

Dermatitis Medical Document Management 40

Dermatology Times

JULY 2, 2024

A medical expert in dermatology examines comprehensive treatment approaches for atopic dermatitis in a 12-year-old African American female patient, focusing on the assessment of topical and non-steroidal therapeutic options.

Dermatitis 36

Dermatitis Treatments Medical Dermatology 36

Dermatology Times

AUGUST 11, 2023

Diego Ruiz Dasilva, MD, FAAD, shares treatment approaches to atopic dermatitis, focusing on medications such as dupilumab and upadacitinib.

Dermatitis 36

Dermatitis Management Medical Treatments 36

The Dermatology Digest

JANUARY 29, 2024

From new topical therapies and novel biologics including nemolizumab and lebrikizumab to OX40 and OX40 ligand monoclonal antibodies, the atopic dermatitis pipeline is full, says Andrew Blauvelt, MD, MBA, an Investigator at Oregon Medical Research Center in Portland. appeared first on The Dermatology Digest.

Dermatitis 28

Dermatitis Therapy Medical Dermatology 28

The Dermatology Digest

APRIL 9, 2024

Patient images are missing in studies of atopic dermatitis (AD), new research shows. “Images are also important for understanding that atopic dermatitis looks very different in different types of skin. This means that as little as 0.3 per thousand of the AD patients were represented in images in the published articles.

Eczema 74

Eczema Dermatitis Education Hospital 74

US Dermatologt Partners

NOVEMBER 25, 2023

Atopic dermatitis (AD) is a multifaceted condition that can significantly impact a patient’s quality of life. I think that dermatitis started showing up once my psoriasis started showing up,” Dean said. She acknowledged that being proactive in asking questions and seeking medical advice sooner may have led to quicker intervention.

Dermatitis 36

Dermatitis Therapy Networking Treatments 36

The Dermatology Digest

MAY 23, 2024

TDD Editorial Advisory Board Member Raj Chovatiya, MD, PhD, the Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago, updates viewers on the true role of Malassezia yeast in the pathophysiology of seborrheic dermatitis and explains how this new understanding is changing the way the condition is treated.

Dermatitis 74

Dermatitis Dermatology Medical 74

The Dermatology Digest

APRIL 7, 2024

A newly developed therapeutic ladder can help guide dermatologists and patients on the use of nonsteroidal treatment options for atopic dermatitis (AD). Ch’en, a medical student at the Albert Einstein College of Medicine in the Bronx, New York, and Peter A. The study appears in Dermatitis.

Treatments 77

Treatments Dermatitis Therapy Safety 77

The Dermatology Digest

JANUARY 4, 2024

Smoking is known to increase the risk of developing atopic dermatitis (AD), even in adolescents. Furthermore, adolescents who use e-cigarettes are at increased risk of developing the “atopic march” consisting of the triad of asthma, atopic dermatitis, and allergic and allergic rhinitis compared to non-smokers,” the study authors write.

Dermatitis 69

Dermatitis Dermatology Medical Education 69

The Dermatology Digest

JANUARY 22, 2024

s ZORYVE topical foam, 0.3%, is now officially available for the treatment of seborrheic dermatitis. Food and Drug Administration (FDA) approved ZORYVE foam for the treatment of seborrheic dermatitis in individuals 9 years of age and older on December 15, 2023. Arcutis Biotherapeutics, Inc.’s

Dermatitis 78

Dermatitis Treatments Innovations Clinic 78

First Derm

JUNE 23, 2024

1] Three main categories of eczema are atopic eczema, contact dermatitis and stasis dermatitis. Despite the potential side effects, appropriate use of topical steroids under medical advice is beneficial for controlling eczema. [4] The American Contact Dermatitis Society recognizes it as an allergen.

Eczema 59

Eczema Ingredients Dermatitis Irritation 59

Dermatology Times

AUGUST 1, 2024

The study focused on the use of Internet resources, number of medical consultations, and factors influencing treatment outcomes.

Document 41

Document Dermatitis Consultation Consultations 41

The Dermatology Digest

MARCH 21, 2024

March is National Sleep Awareness Month, and nighttime itching is known to keep families affected by atopic dermatitis (AD) up at night. Food and Drug Administration for VTAMA (tapinarof) cream, 1% for the topical treatment of atopic dermatitis (AD) in adults and children 2 years of age and older.

Dermatitis 68

Dermatitis Dermatology Medical Treatments 68

First Derm

MARCH 22, 2024

Eczema herpeticum Medically reviewed by The Dermatologists and written by Dr. Alexander Börve In A Nutshell What It Is : Skin infection marked by fever and clusters of itchy blisters, often complicating atopic dermatitis. Those with atopic dermatitis have lower resistance to the herpes infection. What is Eczema Herpeticum?

Eczema 52

Eczema Dermatitis Clinic Medical 52

The Dermatology Digest

JANUARY 14, 2024

People with seborrheic dermatitis who don’t use topical steroids are 3.5 Zoryve foam is a once-daily steroid-free topical for use in all skin and hair types that effectively clears and controls seborrheic dermatitis. Food and Drug Administration (FDA) approved topical roflumilast foam (Zoryve, Arcutis) for seborrheic dermatitis.

Dermatitis 72

Dermatitis Dermatology Office Safety 72

The Dermatology Digest

FEBRUARY 9, 2024

Early skin microbiome and metabolome signatures can predict atopic dermatitis in infants aged 6 to 18 months old, according to new research being presented at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting. The rates of atopic dermatitis were 30.8% in 6-month-old children and 20.8% at 18 months of age.

Dermatitis 74

Dermatitis Moisturization Training Dermatology 74

The Dermatology Digest

FEBRUARY 26, 2024

Shared-decision making focused on weighing risks versus benefits is key when choosing the most appropriate systemic atopic dermatitis (AD) treatment for a patient, according to new research presented at the 2024 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in Washington, DC. some of the biologics).

Treatments 74

Treatments Dermatitis Pharmaceutical Clinic 74

The Dermatology Digest

JANUARY 29, 2024

Food and Drug Administration (FDA) for treatment of seborrheic dermatitis in adult and pediatric patients 9 years of age and older in December 2023. It is the first drug approved for seborrheic dermatitis with a new mechanism of action in over two decades. in seborrheic dermatitis. in seborrheic dermatitis.

Dermatitis 74

Dermatitis Safety Dermatology Treatments 74

The Dermatology Digest

FEBRUARY 14, 2024

Food and Drug Administration (FDA) has accepted Galderma’s Biologics License Applications for nemolizumab for the treatment of patients with prurigo nodularis (PN) and for adolescents and adults with moderate to severe atopic dermatitis (AD). Galderma is planning for multiple regulatory submissions in 2024.

Dermatitis 78

Dermatitis Clinic Safety Dermatology 78

The Dermatology Digest

FEBRUARY 1, 2024

Atopy patch tests (APTs) may be the best way to detect food‐triggered atopic dermatitis (AD), according to a new literature review in Clinical Reviews in Allergy & Immunology. APTs detect sensitization to food proteins responsible for systemic contact dermatitis (SCD), which can then be confirmed by oral food challenge.

Dermatitis 36

Dermatitis Eczema Medical Therapy 36

Dermatology Times

NOVEMBER 20, 2023

Jared Gollob, MD, Chief Medical Officer of Kymera Therapeutics, spoke with Dermatology Times to discuss these trial results.

Office 74

Office Dermatitis Medical Dermatology 74

First Derm

JULY 2, 2024

Online Dermatologist Sweating and Eczema: How to Manage Flare-Ups Eczema and Sweat | Symptoms of eczema | Physiology | How Sweating Affects Eczema | Triggers for Eczema | Related conditions | Managing Sweat to Prevent Eczema Flare-Ups | Treatment Key Takeaways Eczema, particularly atopic dermatitis, flares up with triggers like sweat.

Eczema 59

Eczema Management Dermatitis Irritation 59

First Derm

DECEMBER 28, 2023

When to Consult a Doctor : Understand the importance of professional medical advice for severe cases or when self-care measures are insufficient. Eczema Eyelid Dermatitis: Reddish Patches and Inflammation Characteristic of Eczema Eczema refers to skin conditions characterized by redness, swelling, scaling, oozing/weeping, and/or dryness.

Treatments 45

Treatments Eczema Dermatitis Skin Health 45

The Dermatology Digest

AUGUST 23, 2024

Janus kinase (JAK) inhibitors have had game-changing effects for patients with psoriasis, atopic dermatitis, vitiligo, and alopecia areata, but the use of these potent medications has been associated with JAK inhibitor-associated acne (JAKne). Dr. Friedman agrees.

Dermatology 74

Dermatology Dermatitis Medical Clinic 74

The Dermatology Digest

AUGUST 13, 2024

Drawing upon their 2016 discovery that the interferon response is constantly activated in people with Down syndrome, researchers designed the trial to focus on the autoimmune and inflammatory skin conditions that are common in people with Down syndrome including alopecia areata, psoriasis, atopic dermatitis, and hidradenitis suppurativa.

Clinic 74

Clinic Safety Dermatitis Medical 74

The Dermatology Digest

FEBRUARY 8, 2024

In 2023, dermatologists and their patients welcomed new drugs for acne, psoriasis, alopecia areata, and more, and 2024 promises to deliver real-world data on these medications along with even more therapeutic innovations across the spectrum of cutaneous diseases. We will, for sure, have new medications for chronic urticaria.”

Dermatology 78

Dermatology Eczema Pharmaceutical Dermatitis 78

The Dermatology Digest

JUNE 5, 2024

In the cross-sectional study, researchers analyzed data from more than 215,000 people aged 30 to 70 from the UK Biobank, which includef urine samples and electronic medical records.

Eczema 74

Eczema Diet Dermatitis Dermatology 74

The Dermatology Digest

DECEMBER 15, 2023

Food and Drug Administration (FDA) has given its nod to topical roflumilast foam (Zoryve, Arcutis) for seborrheic dermatitis. The PDE4 inhibitor is the first topical treatment for seborrheic dermatitis with a new mechanism of action in more than 20 years. in seborrheic dermatitis. in seborrheic dermatitis.

Dermatitis 36

Dermatitis Safety Clinic Medical 36

The Dermatology Digest

JULY 10, 2024

for use in moderate to severe atopic dermatitis (AD) in the NHS England. The National Institute for Health and Care Excellence (NICE) now recommends lebrikizumab (Ebglyss, Almirall S.A.) The post NICE Recommends Lebrikizumab for Moderate to Severe AD in the NHS England appeared first on The Dermatology Digest.

Dermatitis 36

Dermatitis Safety Dermatology Marketing 36

First Derm

OCTOBER 9, 2023

Online Dermatologist Rash on Butt: Causes, Diagnosis, and Treatment Causes | Diagnosis | Seeking Medical Attention | Home Remedies | Treatments | Prevention A rash or sores on your buttocks can occur for a variety of causes. Contact dermatitis Contact dermatitis is a common type of rash. When to Seek Medical Attention?

Treatments 45

Treatments Dermatitis Irritation Eczema 45

The Dermatology Digest

MARCH 11, 2024

Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine and a partner at Medical Dermatology Associates of Chicago, discusses which ones works best.

Dermatitis 69

Dermatitis Eczema Dermatology Pharmaceutical 69

The Dermatology Digest

JANUARY 31, 2024

Patients with vitiligo incur direct costs associated with their condition through medical fees, pharmacy expenses, and out-of-pocket costs (e.g., medical equipment and home healthcare). sunscreens, protective clothing, cosmetic concealers, and camouflage products). marriage, career choice, promotions, salary increases, or education).

Hospital 69

Hospital Dermatitis Dermatology Medical 69

Dermatology Times

SEPTEMBER 27, 2023

Jennifer Holman, MD, FAAD, reflects on the improvements in therapeutic treatments and outcomes for patients like Audrey Dean, and how her experience and quality of life has also improved with these medical advances.

Treatments 36

Treatments Dermatitis Medical 36

The Dermatology Digest

FEBRUARY 26, 2024

Impairment in tight junction expression has been shown to contribute to the barrier dysfunction observed in patients with atopic dermatitis. 3 Emollient enhancement, neonatal moisturizer, and barrier lipid replacement have all been discussed as epithelial barrier-protecting agents that may treat and possibly even prevent atopic dermatitis.

Dermatitis 74

Dermatitis Irritation Therapy Dermatology 74